Study monitoring – why is it important?

Guy Healing, Senior Toxicologist at ApconiX is interviewed by Jon Clements of Metamorphic PR What is study monitoring and why is it important to drug discovery projects? Pharma companies need to ensure their drugs are safe but also that they work. In drug development this requires numerous studies to be presented to international regulators, and [...]

By |2019-02-06T10:00:33+00:00February 6th, 2019|Nonclinical Study Monitoring|Comments Off on Study monitoring – why is it important?

ApconiX Welcomes Steve Snyder

ApconiX is delighted to welcome Steve Snyder to the team.  Steve joins the nonclinical study monitoring team and is based in Florida in the United States. Having worked at Wyeth, Eli Lilly, McNeil Pharmaceutical and Charles River, Steve has a wealth of experience in preclinical toxicology as both an outsourcing customer and provider.  He is [...]

By |2019-02-06T09:53:22+00:00February 6th, 2019|Nonclinical Study Monitoring, Careers|Comments Off on ApconiX Welcomes Steve Snyder